Xponential Fitness (XPOF)
(Delayed Data from NYSE)
$16.54 USD
+0.54 (3.38%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $16.54 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Income Statements
Fiscal Year end for Xponential Fitness, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 319 | 245 | 155 | 107 | 129 |
Cost Of Goods | 74 | 66 | 41 | 34 | 47 |
Gross Profit | 245 | 179 | 114 | 72 | 82 |
Selling & Adminstrative & Depr. & Amort Expenses | 205 | 164 | 145 | 65 | 103 |
Income After Depreciation & Amortization | 40 | 15 | -31 | 8 | -21 |
Non-Operating Income | -2 | 1 | 5 | 0 | 0 |
Interest Expense | 39 | 13 | 25 | 21 | 16 |
Pretax Income | -1 | 3 | -51 | -13 | -37 |
Income Taxes | 1 | 1 | 1 | 0 | 0 |
Minority Interest | 16 | -19 | -78 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -2 | 3 | -51 | -14 | -37 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -17 | 22 | 27 | -14 | -37 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 90 | 34 | -12 | 19 | -14 |
Depreciation & Amortization (Cash Flow) | 50 | 19 | 19 | 11 | 7 |
Income After Depreciation & Amortization | 40 | 15 | -31 | 8 | -21 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 39.71 | 25.30 | 22.40 | NA | NA |
Diluted EPS Before Non-Recurring Items | 0.28 | -0.07 | -0.80 | NA | NA |
Diluted Net EPS (GAAP) | -0.44 | -0.87 | -2.85 | NA | NA |
Fiscal Year end for Xponential Fitness, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 90.20 | 80.44 | 77.34 | 70.69 | 71.27 |
Cost Of Goods | 21.62 | 16.27 | 17.94 | 18.07 | 17.13 |
Gross Profit | 68.58 | 64.17 | 59.40 | 52.62 | 54.14 |
SG&A, R&D, and Dept/Amort Expenses | 65.63 | 56.69 | 22.95 | 59.83 | 49.94 |
Income After SG&A, R&D, and Dept/Amort Expenses | 2.95 | 7.48 | 36.45 | -7.21 | 4.20 |
Non-Operating Income | 0.33 | -1.82 | -0.17 | 0.08 | 0.60 |
Interest Expense | 11.49 | 10.64 | 8.63 | 7.98 | 3.96 |
Pretax Income | -8.22 | -4.98 | 27.66 | -15.10 | 0.32 |
Income Taxes | 0.86 | 0.20 | 0.13 | -0.12 | 0.68 |
Minority Interest | 13.42 | -1.80 | 9.15 | -5.00 | -20.35 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -9.08 | -5.18 | 27.52 | -14.98 | -0.37 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -22.49 | -3.38 | 18.38 | -9.98 | 19.98 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 38.86 | 40.22 | 41.59 | 30.75 | 26.82 |
Diluted EPS Before Non-Recurring Items | 0.08 | 0.53 | 0.07 | -0.02 | 0.11 |
Diluted Net EPS (GAAP) | 1.35 | -0.50 | 0.09 | -1.38 | 1.67 |